Negative regulation of gene expression from the HTLV type II long terminal repeat by Rex: Functional and structural dissociation from positive posttranscriptional regulation

AIDS Research and Human Retroviruses

Volumn 12, Issue 6, 1996, Pages 535-546

  Watanabe, Colin T ^a   Rosenblatt, Joseph D ^b,c   Bakker, Andreas ^a   Morgan, Jeffrey P ^a   Luo, Jie ^a   Chun, Susan ^a   Black, Alexander C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; DELETION MUTANT; DISSOCIATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN T CELL LEUKEMIA VIRUS 2; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; TRANSCRIPTION REGULATION; VIRUS GENE;

EID: 0029917266     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.535     Document Type: Article

References (65)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, and Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
2. Yoshida M, Miyoshi I, and Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982;79:2031-2035.
3. Yoshida M, Sciki M, Yamaguchi K, and Takatsuki K: Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984;81:2534-2537.
4. Bhagavati S, Ehrlich G, Kula RW, Kwok S, Sninsky J, Udani V, and Poiesz BJ: Detection of human T-cell lymphoma/leukemia virus type IDNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. N Engl J Med 1988;318: 1141-1147.
5. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calendar A, and de Thé G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2: 407-410.
6. Kalyanaraman VS, Samgadharan MG, Robert-Guroff M, Miyoshi I, Golde D, and Gallo RC: A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-573.
7. Rosenblatt JD, Golde DW, Wachsman W, Giorgi JV, Jacobs A, Schmidt GM, Quan S, Gasson JC, and Chen IS: A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med 1986;315:372-377.
8. Berger JR, Svenningsson A, Raffanti S, and Resnick L: Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II. Neurology 1991;41:85-87.
9. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, and Ross G: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-646.
10. Rosenblatt JD, Tomkins P, Rosenthal M, Kacena A, Chan G, Valderama R, Harrington W Jr, Saxton E, Diagne A, Zhao JQ, et al.: Progressive spastic myelopathy in a patient co-infected with HIV-1 and HTLV-II: Autoantibodies to the human homologue of rig in blood and cerebrospinal fluid. AIDS 1992;6:1151-1158.
11. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, and Chen IS: High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science 1989;244:471-475.
12. Lee H, Swanson P, Rosenblatt JD, Chen ISY, Sherwood WD, Smith DE, Tegtmeier GE, Fernando LP, Fang CT, Osame M, et al.: Relative prevalence and risk factors of HTLV-1 and HTLV-II infection in US blood donors. Lancet 1991;337:1435-1439.
13. Haseltine WA, Sodroski J, Patarca R, Briggs D, Perkins D, and Wong-Staal F: Structure of the 3′ terminal region of type II human T lymphotropic virus: Evidence of a new coding region. Science 1984;225:419-421.
14. Seiki M, Hikikoshi A, Tanguichi T, and Yoshida M: Expression of the px gene of HTLV 1: General splicing mechanism in the HTLV family. Science 1985;228:1532-1535.
15. Wachsman W, Shimotohnov K, Clark SC, Golde DW, and Chen ISY: Expression of the 3' terminal region of human T-cell leukemia viruses. Science 1984;226:177-179.
16. Cann AJ, Rosenblatt JD, Wachsman W, Shah NP, and Chen IS: Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature (London) 1985;318: 571-574.
17. Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, and Pavlakis GN: The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985;229:675-679.
18. Fujisawa J, Seiki M, Sato M, and Yoshida M: A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 Tax of HTLV-I. EMBO J 1986;5:713-718.
19. Inoue WI, Yoshida M, and Seiki M: Transcriptional (p40x) and posttranscriptional (p27xIII) regulators are required for the expression and replication of human T-cell leukemia virus type 1 genes. Proc Natl Acad Sci USA 1987;84:3653-3657.
20. Sodroski J, Rosen C, Goh WC, and Haseltine W: A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus. Science 1985;228:1430-1434.
21. Paskalis H, Felber BK, and Pavlakis GN: Cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer. Proc Natl Acad Sci USA 1986;83:6558-6562.
22. Shimotohno K, Takano M, Teruuchi T, and Miwa M: Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription. Proc Natl Acad Sci USA 1986;83:8112-8116.
23. Ohtani K, Nakamura M, Saito S, Noda T, Ito Y, Sugamura K, and Hinuma Y: Identification of two distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene expression. EMBO J 1987;6:389-395.
24. Hirai H, Fujisawa J, Suzuki T, Ueda K, Muramatsu M, Tsuboi A, Arai N, and Yoshida M: Transcriptional activator Tax of HTLV-1 binds to the NF-kappa B precursor p105. Oncogene 1992; 7:1737-1742.
25. Beraud C, Sun SC, Ganchi P, Ballard DW, and Greene WC: Human T-cell leukemia virus type 1 tax associates and is negatively regulated by the NFKB2 p100 gene product: Implications for viral latency. Mol Cell Biol 1994;14:1374-1382.
26. Yoshimura T, Fujisawa J, and Yoshida M: Multiple cDNA clones encoding nuclear proteins that bind to the tax-dependent enhancer of HTLV-1: All contain a leucine zipper structure and basic amino acid domain. EMBO J 1990;9:2537-2542.
27. Fujii M, Tsuchiya H, Chuhjo T, Akizawa T, and Seiki M: Interaction of HTLV-1 Tax 1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev 1992;6:2066-2076.
28. Leung K and Nabel GJ: HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature (London) 1988;333:776-778.
29. Ruben S, Poteat H, Tan TH, Kawakami K, Roeder R, Haseltine W, and Rosen CA: Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science 1988;241:89-92.
30. Nimer SD, Gasson JC, Hu K, Smalberg I, Williams JL, Chen IS, and Rosenblatt JD: Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Oncogene 1989;4:671-676.
31. Ejima E, Rosenblatt JD, Massari M, Quan E, Stephens D, Rosen CA, and Prager D: Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins. Blood 1993;81:1017-1024.
32. Fujii M, Sassone-Corsi P, and Verma IM: c-fos-promoter transactivation by the tax 1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1988;85:8526-8530.
33. Ballaun C, Farrington GK, Dobrovnik M, Rusche J, Hauber J, and Bohnlein E: Functional analysis of human T-cell leukemia virus type I rex response element: Direct RNA binding of Rex protein correlates with in vivo activity. J Virol 1991;65:4408-413.
34. Black AC, Chen IS, Arrigo S, Ruland CT, Allogiamento T, Chin E, and Rosenblatt JD: Regulation of HTLV-II gene expression by Rex involves positive and negative cis-acting elements in the 5′ long terminal repeat. Virology 1991;181:433-444.
35. Black AC, Ruland CT, Yip MT, Luo J, Tran B, Kalsi A, Quan E, Aboud M, Chen ISY, and Rosenblatt JD: Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure. J Virol 1991;65:6645-6653.
36. Hidaka M, Inoue J, Yoshida M, and Seiki M: Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J 1988;7:519-523.
37. Rosenblatt JD, Cann AJ, Slamon DJ, Smalberg IS, Shah NP, Fujii J, Wachsman W, and Chen IS: HTLV-II transactivation is regulated by the overlapping tax/rex nonstructural genes. Science 1988;240:916-919.
38. Toyoshima H, Itoh M, Inoue J, Seiki M, Takaku F, and Yoshida M: Secondary structure of the human T-cell leukemia virus type 1 rex-responsive element is essential for rex regulation of RNA processing and transport of unspliced RNAs. J Virol 1990; 64:2825-2832.
39. Yip MT, Dynan WS, Green PL, Black AC, Arrigo SJ, Torbati A, Heaphy S, Ruland C, Rosenblatt JD, and Chen ISY: Human T-cell leukemia virus (HTLV) type II Rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type I Rev-responsive element. J Virol 1991;65:2261-2272.
40. Ohta M, Nyunoya H, Tanaka H, Okamoto T, Akagi T, and Shimotohno K: Identification of a cis-regulatory element involved in accumulation of human T-cell leukemia virus type II genomic mRNA. J Virol 1988;62:4445-4451.
41. Seiki M, Hikikoshi A, and Yoshida M: The U5 sequence is a cis-acting repressive element for genomic RNA expression of human T cell leukemia virus type I. Virology 1990;176:81-56.
42. Bakker A, Li X, Ruland CT, Stephens DW, Black AC, and Rosenblatt JD. HTLV-II Rex inhibits pre-mRNA splicing in vitro at an early slage of spliceosome formation. Submitted.
43. Hammes SR and Greene WC: Multiple arginine residues within the basic domain of HTLV-I Rex are required for specific RNA binding and function. Virology 1993;193:41-19.
44. Siomi H, Shida H, Nam SH, Nosaka T, Maki M, and Hatanaka M: Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell 1988;55:197-209.
45. Bohnlein S, Pirker FP, Hofer L, Zimmermann K, Bachmayer H, Bohnlein E, and Hauber J: Transdominant repressors for human T-cell leukemia virus type I rex and human immunodeficiency virus type 1 rev function. J Virol 1991;65:81-88.
46. Hofer L, Weichselbraun I, Quick S, Farrington GK, Bohnlein E, and Hauber J: Mutational analysis of the human T-cell leukemia virus type I trans-acting rex gene product. J Virol 1991; 65:3379-3383.
47. Weichselbraun I, Farrington GK, Rusche JR, Bohnlein E, and Hauber J: Definition of the human immunodeficiency virus type I Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange. J Virol 1992;66:2583-2587.
48. Black AC, Nimer SD, Chen ISY, and Rosenblatt JD: The effect of Tax and Rex proteins of HTLV-II on viral and cellular gene regulation. In: UCLA Symposium on Human Retroviruses (Groopman J, Chen ISY, Essex M, and Weiss R, eds.), Vol. 119. Liss, New York, 1990, pp. 33-47.
49. Kunkel TA, Bebenek K, and McClary J: Efficient site-directed mutagenesis using uracil-comaining DNA. Methods Enzymol 1991;204:125-139.
50. Greene WC, Kronke M, Leonard WJ, and Depper JM: Deregulation of interleukin-2 receptor gene expression in HTLV-I-induced adult T-cell leukemia. Science 1985;228: 1215-1217.
51. Seed B and Sheen JY: A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 1988;67:271-277.
52. Yew PR and Berk AJ: Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature (London) 1992;357:82-85.
53. Gitlin SD, Lindholm PF, Marriott SJ, and Brady JN: Transdominant human T-cell lymphotropic virus type I TAXI mutant that fails to localize to the nucleus. J Virol 1991; 65:2612-2621.
54. Heder A, Paca-Uccaralertkun S, and Boros I: Mutational analysis of the HTLV-I trans-activator. Tax. FEBS Lett 1991;292: 210-212.
55. Katahira J, Ishizaki T, Sakai H, Adachi A, Yamamoto K, and Shida H: Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding. J Virol 1995; 69:3125-3133.
56. Hope TJ, Bond BL, McDonald D, Klein NP, and Parslow TG: Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J Virol 1991;65:6001-6007.
57. Bogerd H and Greene WC: Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J Virol 1993;67:2496-2502.
58. Weichselbraun I, Berger J, Dobrovnik M, Bogerd H, Grassmann R, Greene WC, Hauber J, and Bohnlein E: Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: Implications for trans dominance. J Virol 1992;66:4540-4545.
59. Herschbach BM and Johnson AD: Transcriptional repression in eukaryotes. Annu Rev Cell Biol 1993;9:479-509.
60. Jackers P, Defechereux P, Baudoux L, Lambert C, Massaer M, Merville-Louis MP, Rentier B, and Piette J: Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein. J Virol 1992;66:3899-3903.
61. Michael N and Roizman B: Repression of the herpes simplex virus 1 alpha 4 gene by its gene product occurs within the context of the viral genome and is associated with all three identified cognate sites. Proc Natl Acad Sci USA 1993;90: 2286-2290.
62. Dery CV, Herrmann CH, and Mathews MB: Response of individual adenovirus promoters to the products of the E1A gene. Oncogene 1987;2:15-23.
63. Sadaie MR, Benaissa ZN, Cullen BR, and Wong-Staal F: Human immunodeficiency virus type I rev protein as a negative trans-regulator. DNA 1989;8:669-674.
64. Debrus S, Sadzot-Delvaux C, Nikkels AF, Piette J, and Rentier B: Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol 1995;69:3240-3245.
65. Kinoshita T, Shimoyama M, Tobinai K, Ito M, Ito S, Ikeda S, Tajima K, Shimotohno K, and Sugimura T: Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci USA 1989;86:5620-5624.